Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises SEB in connection with its SEK 15 billion rights issue
Mandate

Vinge advises SEB in connection with its SEK 15 billion rights issue

February 05, 2009

Skandinaviska Enskilda Banken AB (publ) has resolved to carry out a new share issue with preferential rights for the shareholders. Through the rights issue, which is fully committed and underwritten, the bank will raise approximately SEK 15 billion excluding transaction costs. The rights issue is subject to approval by the bank’s annual general meeting on 6 March 2009.

Vinge’s team is led by Hans Wibom and Mattias Friberg. The team also include, among others, Emil Hedberg, Petter Kjöllerström and Peter Larsson.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026